Oral Probiotic Supplementation in Pregnancy to Reduce Group B Streptococcus Colonisation (OPSiP trial): study protocol for a double-blind parallel group randomised placebo trial

Introduction Group B streptococcus (GBS), or Streptococcus agalactiae, remains a leading cause of neonatal morbidity and mortality. Canadian guidelines advise universal maternal screening for GBS colonisation in pregnancy in conjunction with selective antibiotic therapy. This results in over 1000 pr...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Beth A Payne, Patricia Johnson, Patricia Janssen, Michelle Butler, Kelly Hayes, Cecilia Jevitt, Will Johnston
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMJ Publishing Group 2024-02-01
Serier:	BMJ Open
Online adgang:	https://bmjopen.bmj.com/content/14/2/e076455.full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!